News

The official results of the BRACELET-01 (PrECOG 0113) trial have been published in Clinical Cancer Research, detailing the ...
Within the family program agenda, Aardvark's Chief Medical Officer, Manasi Jaiman, M.D., will join a panel of clinicians to discuss the details of the company's ongoing Phase 3 HERO study.
Arkay Beverages, the pioneer in zero-proof spirits, is proud to announce that its entire range — including whisky, vodka, rum ...
Scientists have found a way to use the bacteria E.Coli to convert plastic waste into a popular painkiller, a study said ...
From the Scuola Superiore di Studi e di Perfezionamento “S. Anna” (T.S.), Pisa; Department of Reproductive Medicine and Child Development (T.S., A.R.G.) and Cellular and Developmental Biology Division ...
We present a combined experimental and theoretical study of the electronic transport through single-molecule junctions based on nitrile-terminated biphenyl derivatives. Using a scanning tunneling ...
Phase 2a data on Skye Bioscience's (NASDAQ:SKYE) cannabinoid-1 receptor blocker (CB1) for obesity, nimacimab, should be ...
Geneva, Switzerland, June 19, 2025 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company ...
SandboxAQ releases over 5 million AI-generated protein-drug structures to accelerate drug discovery and rival lab testing.
Department of Chemistry & Biochemistry, University of California, Los Angeles, 607 Charles E. Young Drive East, Los Angeles, California 90095 Article Views are the ...